The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
My opinion is that this RNS continues to demonstrate the increasing irrelevance of the US legal action to Eqtec’s continued progress.
Piggy-backing these projects where the planning has been agreed in principle (and surely no Authority will be stupid enough not to approve improved environmental concession), is the quickest way to get things started. Partially funding the project jump starts it (soft money following hard money and all that).
As to the SP; increasing revenue, not necessarily profits will probably move it. Still crazily undervalued IMO, I still hold a massive position which I will hold whatever the rest of the market does since this will thrive whatever happens to the economy in general.
I also thought telling that Newlands mentioned the immunotherapy application - he clearly understands the importance of this and I am sure there will be verification of the Crete results whilst the FDA application time is playing out. As I have mentioned if confirmed it will be this that ensures a machine is required in every cancer hospital!
Thank you for posting the presentation....
I must say it was MUCH more convincing in that both Newlands and the FD sounded as if they understood the clinical picture and where Parsotix stands in terms of analysis/ongoing therapy. I am not sure whether practice makes perfect or whether they have chatted to some clinicians in the interim to really nail it but that was excellent - I have increased my investment accordingly!
Just listened to the presentation.
As I have commented before Newlands doesn’t really present even a simplified accurate clinical picture which worries me....
Also I do think they have been slow to obtain the normal blood samples following Covid lockdown....
However Jupiter selling some shares therefore providing a cheap entry; the proximity of FDA submission and IMO the likelihood of acceptance(a process not a drug); the way routine analysis of CTCs can revolutionise oncological practice; good margins and likelihood (IMO) of an American listing providing further development funds at much less dilution have made this a buy.
I would also go back to the last RNS re:immunotherapy. If this work can be reproduced in a better regarded lab (sorry all proud Cretians), then this is MASSIVE. This test alone would put parsortix machines in every regional immunohistochemistry dept in the UK. Immunotherapy is insanely expensive and NHS reimbursed so working out who it would work on (curiously not the top priority of pharma), will save billions/yr in the UK alone. Pretty much every cancer patient treated these days would need the test... so about 1/3 of is all!
So back in end of last week.
GLA
The response was interesting in offering no new information as far as I can tell... Whereas I did think Eqtec’s response refuted The claims made by Aires.
Personally I have put the whole thing to bed in my mind until the case is actually ‘served’ if that is the correct terminology. My suspicion is 75:25 that this will slowly be forgotten and the case not served, and as suggested even if served likely to be settled before court.
And there you go... The trade at 14:45 for a million or so For ..47 told you there was a big buy in the background and shown as 17.5mil at .465, balancing the day nicely. Carry on mugging the placing particlpants with no balls!
I must say I do think that RNS is such a brilliant rebuttal. Para by para, reading between the lines:
'We have the best quality patent lawyers.
You haven't actually filed the complaint, but lets just illustrate what a mistake that would be. You need to withdraw your complaint immediately.
You now significantly risk compromising any IP around gasification you may claim because if contested it is likely your patents will be proven invalid by your OWN submission of evidence of historically sold gasifiers by Eqtec. You will look incompetent. Any claim this is violating a 'life's work/the little man's toil' is clearly nonsense when the patents were picked up in a bankruptcy fire sale.
We attempted to resolve this amicably but you refused and were duplicitous in the way you behaved (further risking your patents and moral high ground in the case). This really hinges on the fact that you know our tech is better and can't compete.
As above, withdraw this immediately because it will be very costly for you and your company, and rather than allowing both companies to potentially prosper. If not you risk your own company.
We are fully committed to the project because it will greatly benefit the community and do you really want to pick a fight with the state of California as well.
Did we mention we have hot **** lawyers?'
Anyhow, will be interesting to see the response/whether the claim is withdrawn. I suspect it will never be filed and just be gently forgotten.